Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heron Therapeutics Inc (NASDAQ:HRTX)

15.05
Delayed Data
As of Jun 23
 -0.35 / -2.27%
Today’s Change
12.21
Today|||52-Week Range
24.00
+14.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues0.000.001.3M3.6M
 
 
 
Cost of Goods Sold0.000.0035.0K857.0K
 
 
 
Depreciation And Amortization251.0K304.0K306.0K329.0K
 
 
 
 
 
 
Operating ExpensesGross Income-251.0K-304.0K938.0K2.4M
 
 
 
 
 
General Expenses42.8M42.2M47.7M49.8M
 
 
 
 
 
Research And Development27.3M25.5M29.5M32.6M
 
 
 
 
 
Total Operating Expenses43.1M42.5M48.1M51.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-43.1M-42.5M-46.8M-47.4M
 
 
 
 
 
Extraordinary Charge0.00-5.2M---1.9M
 
 
 
Interest Expense On Debt160.0K--1.6M1.0M
 
 
 
 
Other Expenses0.00-775.0K436.0K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-43.2M-48.5M-48.0M-50.3M
 
 
 
 
 
Net Income-43.2M-48.5M-48.0M-50.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.0M39.1M39.3M50.5M
 
 
 
 
 
Shares To Calculate EPS Diluted37.0M39.1M39.3M50.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.17-$1.24-$1.22-$1.00
 
 
 
 
 
EPS Diluted-$1.17-$1.24-$1.22-$1.00